Skip to main navigation Skip to search Skip to main content

Drug repurposing identifies a synergistic combination therapy with imatinib mesylate for gastrointestinal stromal tumor

  • University of Kansas

Research output: Contribution to journalArticlepeer-review

34 Scopus citations

Fingerprint

Dive into the research topics of 'Drug repurposing identifies a synergistic combination therapy with imatinib mesylate for gastrointestinal stromal tumor'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science